We are thrilled to announce that CFBD Director Prof Martin Scanlon has been appointed as the new Theme Leader for Medicinal Chemistry at Monash University in Parkville.

Professor Scanlon will lead a team of scientists focused on synthetic medicinal chemistry, structure-based drug design, fragment screening and academic drug discovery.  In addition to CFBD and the Monash Fragment Platform, the Medicinal Chemistry Theme also comprises the Australian Translational Medicinal Chemistry Facility and MedChem Australia (in collaboration with WEHI and The University of Sydney).

More about Prof Scanlon’s appointment and career highlights can be found here.